← Latest Filings
Y

Yeleswaram Krishnaswamy

Chief Development Officer

Open-market buys
0
$0 total
Open-market sells
9
$4.1M total
Tracking since
Apr 2026
Open-market sale — $827K
Open-market sale — $1.0M
Open-market trades from the last two years.
195,862 Common Stock in RAPP
Held directly · as of 2026-08-25
Rapport Therapeutics, Inc.
CIK 0002012593